Lung cancer rising among non-smokers — here's why
The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising ...
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...
Slain Melvindale officer's brother, others rally around police chief amid cancer fight
The department has grappled with an officer's death and scrutiny around another's use of force in the past year.
Purple Biotech advances NT219 into Phase 2 head, neck cancer trial
Purple Biotech (PPBT) is advancing into a Phase 2 study with NT219 in patients with recurrent/metastatic squamous cell carcinoma of the head ...
Targeted Oncology12h
FDA Fast-Tracks IBI363 in Squamous NSCLC
The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...
Medscape8d
What Defines High-Risk SCC Is Not Always Clear-Cut
CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus ...
Targeted Oncology1d
Brahmer Considers First-Line Immunotherapy Options in Metastatic NSCLC
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
Pharmabiz1d
Innovent receives second fast track designation from US FDA for IBI363 in squamous non-small cell lung cancer
San Francisco, US Tuesday, February 18, 2025, 09:00 Hrs [IST] ...